abstract |
The present invention provides methods of using antibodies and the like that bind human GFR [alpha] 3. According to certain embodiments disclosed herein, the antibody is a fully human antibody that binds human GFR [alpha] 3. The antibodies of the present disclosure are useful in the treatment of diseases or disorders associated with one or more GFR [alpha] 3 biological activities, including the treatment of acute or chronic pain diseases, or inflammatory diseases. |